The emerging approach of the medication represents a major development in the management of type 2 diabetes. Different to existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide234580.bloggosite.com/49989525/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment